Volume 62, Issue 6, Pages (December 2012)

Slides:



Advertisements
Similar presentations
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Comparison of MR/Ultrasound Fusion–Guided Biopsy With.
Advertisements

Prostate cancer update Suresh GANTA Consultant urological surgeon Manor Hospital.
Date of download: 10/12/2017 Copyright © ASME. All rights reserved.
74-year-old man with stage T2a Gleason score prostate cancer (prostate specific antigen = ng/mL) in right transition zone (TZ) with history.
Results of Targeted Biopsy in Men with Magnetic Resonance Imaging Lesions Classified Equivocal, Likely or Highly Likely to Be Clinically Significant Prostate.
Volume 71, Issue 6, Pages (June 2017)
Volume 72, Issue 2, Pages (August 2017)
Volume 69, Issue 1, Pages (January 2016)
Multi-parametric Approach
The Value of Contrast-Enhanced Ultrasonography Combined with Real-Time Strain Elastography in the Early Diagnosis of Prostate Cancer Chang Ying 1 ;Yang.
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Donald R. Murphy, DC, Nicholas J. Morris, DC 
Tumour-Targeted Treatment Intensification for Prostate Cancer Using Magnetic Resonance Imaging Guidance  Jessy Abed, RTT, MHScMRS, Jenny Lee, MMath, Tim.
Volume 70, Issue 5, Pages (November 2016)
Volume 56, Issue 6, Pages (December 2009)
Volume 72, Issue 6, Pages (December 2017)
Volume 53, Issue 4, Pages (April 2008)
Volume 52, Issue 1, Pages (July 2007)
Potential and Limitations of Diffusion-Weighted Magnetic Resonance Imaging in Kidney, Prostate, and Bladder Cancer Including Pelvic Lymph Node Staging:
Volume 52, Issue 4, Pages (October 2007)
Volume 67, Issue 3, Pages (March 2015)
Volume 69, Issue 1, Pages (January 2016)
European Urology Oncology
Diagnostic Value of MRI in a Pelvic Mass of Prostatic Origin
Natural History of Pathologically Benign Cancer Suspicious Regions on Multiparametric Magnetic Resonance Imaging Following Targeted Biopsy  Darren J.
Dynamic Contrast-Enhanced MRI for Preoperative Identification of Localised Prostate Cancer  Arnauld Villers, Philippe Puech, Xavier Leroy, Jacques Biserte,
Volume 65, Issue 6, Pages (June 2014)
Volume 72, Issue 3, Pages (September 2017)
Volume 66, Issue 1, Pages (July 2014)
Deok Hyun Han, Yong Sang Jeong, Myung-Soo Choo, Kyu-Sung Lee 
Assessing the validity of Prostate Imaging Reporting and Data System version 2 (PI- RADS v2) scoring system in diagnosis of peripheral zone prostate cancer 
Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal.
Volume 70, Issue 3, Pages (September 2016)
Prostate Cancer Detection: A View of the Future
Volume 62, Issue 1, Pages (July 2012)
Volume 69, Issue 6, Pages (June 2016)
Volume 67, Issue 4, Pages (April 2015)
Prostate Imaging-Reporting and Data System Steering Committee: PI-RADS v2 Status Update and Future Directions  Anwar R. Padhani, Jeffrey Weinreb, Andrew.
Volume 59, Issue 6, Pages (June 2011)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 53, Issue 4, Pages (April 2008)
Volume 54, Issue 3, Pages (September 2008)
Volume 65, Issue 6, Pages (June 2014)
Tillmann Loch, Pat Fox Fulgham  European Urology 
Volume 68, Issue 4, Pages (October 2015)
Clinical Utility of Multiparametric Magnetic Resonance Imaging as the First-line Tool for Men with High Clinical Suspicion of Prostate Cancer  Valeria.
Volume 65, Issue 4, Pages (April 2014)
Volume 68, Issue 6, Pages (December 2015)
Is It Necessary to Detect All Prostate Cancers in Men with Serum PSA Levels
Volume 65, Issue 1, Pages (January 2014)
Volume 50, Issue 5, Pages (November 2006)
Biopsy of the Vesico-Urethral Anastomosis after Radical Prostatectomy: When and How  Vincenzo Scattoni, Marco Roscigno, Marco Raber, Paolo Consonni, Luigi.
Contralateral microemboli following carotid artery stenting in patients with a contralateral internal carotid artery occlusion  Kevin Casey, MD, Elizabeth.
Donald R. Murphy, DC, Nicholas J. Morris, DC 
Role of 3T multiparametric-MRI with BOLD hypoxia imaging for diagnosis and post therapy response evaluation of postoperative recurrent cervical cancers 
Volume 75, Issue 4, Pages (April 2019)
Volume 73, Issue 1, Pages (January 2018)
Jean J.M.C.H. de la Rosette, Vladimir Mouraviev, Thomas J. Polascik 
Volume 71, Issue 3, Pages (March 2017)
Volume 65, Issue 3, Pages (March 2014)
Role of Transurethral Resection of the Prostate and Biopsy of the Peripheral Zone in the Same Session after Repeated Negative Biopsies in the Diagnosis.
Volume 69, Issue 1, Pages (January 2016)
The Role of Systematic and Targeted Biopsies in Light of Overlap on Magnetic Resonance Imaging Ultrasound Fusion Biopsy  Neal Patel, Eliza Cricco-Lizza,
The Comparability of Models for Predicting the Risk of a Positive Prostate Biopsy with Prostate-Specific Antigen Alone: A Systematic Review  Fritz Schröder,
Not All Multiparametric Magnetic Resonance Imaging–targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection.
Volume 54, Issue 3, Pages (September 2008)
Technical Innovations and Patient Support in Radiation Oncology
Introduction European Urology Supplements
Assessing a Patient’s Individual Risk of Biopsy-detectable Prostate Cancer: Be Aware of Case Mix Heterogeneity and A Priori Likelihood  Jan F.M. Verbeek,
European Urology Oncology
Presentation transcript:

Volume 62, Issue 6, Pages 986-996 (December 2012) Validation of the European Society of Urogenital Radiology Scoring System for Prostate Cancer Diagnosis on Multiparametric Magnetic Resonance Imaging in a Cohort of Repeat Biopsy Patients  Daniel Portalez, Pierre Mozer, François Cornud, Raphaëlle Renard-Penna, Vincent Misrai, Matthieu Thoulouzan, Bernard Malavaud  European Urology  Volume 62, Issue 6, Pages 986-996 (December 2012) DOI: 10.1016/j.eururo.2012.06.044 Copyright © 2012 Terms and Conditions

Fig. 1 Target definition and elastic surface registration, axial representations of the prostate, are presented in the first column. (a) T2-weighted magnetic resonance imaging (MRI), diffusion-weighted imaging MRI, and dynamic contrast-enhanced MRI demonstrate a European Society of Urogenital Radiology score sum (ESUR-S) of 13 lesion in the anterior aspect of the right transition zone that is highlighted by a yellow tag in the first column. (b) Surface reconstruction from MRI; the prostate volume is contoured in the axial, sagittal, and coronal T2-weighted MRI acquisitions. (c) Surface reconstruction of three-dimensional transrectal ultrasonography (3D TRUS). (d) Elastic surface registration by means of an algorithm that controls the prostate constraints driven by changes in the patient’s positioning, deformations in rectal wall, or displacement of the prostate. After registration, the MRI-suspicious areas highlighted by colored tags could alternatively be displayed within MRI- or 3D TRUS–registered volumes. European Urology 2012 62, 986-996DOI: (10.1016/j.eururo.2012.06.044) Copyright © 2012 Terms and Conditions

Fig. 2 Postprocedure analysis of the European Society of Urogenital Radiology (ESUR) characteristics of multiparametric magnetic resonance imaging (mpMRI) Digital Imaging and Communications in Medicine archives; for clarity’s sake, only the pictures pertaining to the target are presented. (a,b) Tagging of a suspicious focus in the right peripheral zone. (c,d) Transfer to the three-dimensional transrectal ultrasonography (3D TRUS) model by elastic surface registration ([c] T2-weighted magnetic resonance imaging; [inset] 3D TRUS). (e) Recording of the spatial location of the cores by repeating 3D TRUS with the needle left in place. (f) Reverse transfer to the mpMRI model. The actual ESUR characteristics of the site sampled by the cores was determined after the procedure by comparison with the initial mpMRI Digital Imaging and Communications in Medicine archives (a). European Urology 2012 62, 986-996DOI: (10.1016/j.eururo.2012.06.044) Copyright © 2012 Terms and Conditions

Fig. 3 Absolute number of cores taken and proportion positive for cancer (in parentheses) per sector. Random systematic cores are in red (n=1125), and targeted cores are in blue (n=399). L=left; R=right. European Urology 2012 62, 986-996DOI: (10.1016/j.eururo.2012.06.044) Copyright © 2012 Terms and Conditions

Fig. 4 Proportion of cores positive for cancer according to T2-weighted (T2w) magnetic resonance imaging (MRI), diffusion-weighted imaging (DWI) MRI, and dynamic contrast-enhanced (DCE) MRI European Society of Urogenital Radiology (ESUR) score sum. The number of cores taken for each condition is presented in parentheses. European Urology 2012 62, 986-996DOI: (10.1016/j.eururo.2012.06.044) Copyright © 2012 Terms and Conditions

Fig. 5 Proportion of cores positive for cancer according to the European Society of Urogenital Radiology score sum (ESUR-S), the ESUR-S in five increments, and the five classes of the Likert scale. European Urology 2012 62, 986-996DOI: (10.1016/j.eururo.2012.06.044) Copyright © 2012 Terms and Conditions

Fig. 6 Receiver operating characteristic curves for (A) the European Society of Urogenital Radiology (ESUR) score sum and (B) the Likert scale. CI=confidence interval. European Urology 2012 62, 986-996DOI: (10.1016/j.eururo.2012.06.044) Copyright © 2012 Terms and Conditions